This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit October 08, 2014


 

Advertisement

Imaging techniques for treatment evaluation for metastatic breast cancer
Agency for Healthcare Research and Quality
Several imaging modalities, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), PET/CT, and bone scintigraphy, are used to evaluate the effects of treatment for metastatic breast cancer. However, as outlined in guidelines from the National Comprehensive Cancer Network and the National Institute for Health and Clinical Excellence, evidence regarding the accuracy and effectiveness of these modalities to evaluate treatment of metastatic breast cancer is lacking, even though the types and results of imaging may strongly affect patient outcomes.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


Advertisement


'Financial toxicity:' Who's really to blame for high cancer drug prices?
The Wall Street Journal
File this under "the blame game." The issue of expensive cancer drugs is hardly new, of course, but 60 Minutes aired a recent segment that likely helped highlight the controversy for the mass audience that watches the popular news program. The episode, however, is unlikely to have helped the pharmaceutical industry. Why?
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Important webinar — Caring for patients' spiritual needs: Resources for all providers
American Psychosocial Oncology Society
Plan now to join this webinar on Oct. 24, 2014, from 2:30 to 4:00 pm Eastern Time to participate in a program that will discuss the nature of religiosity/spirituality (R/S) in cancer care, strategies for initiating conversations about patients’ R/S, and strategies for effective collaboration with health care chaplains. The webinar is intended for providers in all disciplines with varying degrees of experience in caring for patients with spiritual needs. For detailed information, contact the American Psychosocial Oncology Society (APOS) Headquarters.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement
SPONSORED CONTENT


One-third of cancer patients experienced anxiety, mental health disorders
HemOnc Today
About one in three patients with cancer experienced some level of clinically relevant mental health challenge, such as anxiety, depressive disorders or adjustment disorders, according to results of a multicenter German study. Prior studies have demonstrated elevated levels of distress among patients with cancer. However, those studies varied in quality due to small sample sizes, disparate diagnostic criteria and assessment standards, and a disproportionate representation of patients with breast cancer, according to background information provided by researchers.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


HHS releases 13th Report on Carcinogens
National Institutes of Health
Four substances have been added in the U.S. Department of Health and Human Services 13th Report on Carcinogens, a science-based document that identifies chemical, biological, and physical agents that are considered cancer hazards for people living in the United States. The new report includes 243 listings.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement
PRODUCT SHOWCASE
  Take the Navigator Exam AND Enjoy the Beach.
Why not come to Florida, take the Navigator certification exam and enjoy the beach too. Boynton Beach, Florida will be the next location where you can get your CN-B*. Nurses, PAs, RTs, LSWs, RTs, and advocates are all welcome.
  • Florida announcement
  • Navigator application
  • Membership application
  •  


    First pictures of BRCA2 protein show how it works to repair DNA
    Phys.org
    Scientists have taken pictures of the BRCA2 protein for the first time, showing how it works to repair damaged DNA. Mutations in the gene that encodes BRCA2 are well known for raising the risk of breast cancer and other cancers. Although the protein was known to be involved in DNA repair, its shape and mechanism have been unclear, which makes it impossible to target with therapies.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Improved survival for inoperative liver cancer through a combined therapy
    Oncology Nurse Advisor
    Patients with inoperable advanced hepatocellular carcinoma (HCC) may have a chance to live significantly longer by receiving a combined therapy, according to recently reported, mature results from a trial. The multicenter phase II clinical trial, conducted by the Asia-Pacific Hepatocellular Carcinoma Trials Group and led by the National Cancer Centre Singapore (NCCS) and Singapore General Hospital (SGH), evaluated the efficacy of combining two existing treatment modalities: sorafenib and selective internal radiation therapy (SIRT).
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    ASCO calls for new action to address obesity and cancer
    American Society of Clinical Oncology
    The American Society of Clinical Oncology (ASCO) called for increased education, research and advocacy to reduce the toll of obesity, both as a leading cause of cancer and a complication in the care of cancer patients. ASCO recommendations outline four critical priorities, including increased education and awareness about links between obesity and cancer; development of new physician tools and resources; intensified and highly coordinated research; and policy changes to increase access to obesity screening, diagnosis, and treatment. The statement was published online on Oct. 1, 2014, in the Journal of Clinical Oncology.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Thyroid carcinoma: Biomarker reveals cancer cause
    Health Canal
    The expression of the protein CLIP2 provides information on whether a papillary thyroid carcinoma was induced by radiation or had a sporadic origin. With this discovery, scientists from the Helmholtz Zentrum München have identified a new biomarker for the diagnosis of the cancer cause. Their findings have been published in the journal Oncogene.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    TRENDING ARTICLES
    Missed last week's issue? See which articles your colleagues read most.

        More high-risk surgical patients are choosing breast reconstruction procedures after mastectomy (American College of Surgeons)
    Scientists detect early sign of pancreatic cancer (CBS News)
    Important Webinar — Caring for patients' spiritual needs: Resources for all providers (American Psychosocial Oncology Society)
    Many lung cancer clinical trials exclude prior cancer patients (News-medical.net)
    Radiation therapy for early breast cancer did not increase lymphedema risk (Oncology Practice)

    Don't be left behind. Click here to see what else you missed.


    Two experts discuss mammography issues on The Recovery Room Show
    NAPBC
    The Recovery Room Show recently launched a new episode discussing the benefits and controversies surrounding mammographic screening. In the episode, host Frederick L. Greene, MD, FACS, a surgical oncologist from Charlotte, N.C., and a member of the Commission on Cancer since 2000, talks with two leading experts in the field. The show includes a discussion on common concerns with mammography, the role of insurance companies, MRIs, and a high-profile recent Canadian study that cast doubt on the abilities of the screening tool.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Targeted combination therapy halts disease and extends life in advanced melanoma
    Oncology Nurse Advisor
    A targeted combination drug therapy has shown efficacy in a study reporting major declines in the risk of disease progression and death in people with metastatic melanoma. The multicenter, double-blind, randomized, phase 3 trial compared oral dabrafenib (150 mg twice daily) and oral trametinib (2 mg once daily) combination therapy with oral dabrafenib (150 mg twice daily) and placebo.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Pursuing Excellence through NAPBC Accreditation
    NAPBC
    Whether you are preparing for a re-accreditation survey, first survey, or looking for information on the National Accreditation Program for Breast Centers (NAPBC), this education program gives you the information you need.

    Pursuing Excellence through NAPBC Accreditation is the only education program developed and taught by NAPBC staff, board members, and surveyors. This program prepares your breast center for survey and helps staff not familiar with the NAPBC standards understand their role in the accreditation process.


    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE
     
    Advertisement



    The CoC Brief

    Colby Horton, Vice President of Publishing, 469.420.2601
    Download media kit

    Samantha Emerson, Content Editor, 469.420.2669
    Contribute news

    Disclaimer: The CoC Brief is a digest of the most important news selected for the American College of Surgeons Commission on Cancer from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Commission on Cancer does not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons and the Commission on Cancer.


    Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

    This edition of The CoC Brief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

    Recent issues

    Oct. 1, 2014
    Sept. 24, 2014
    Sept. 24, 2014
    Sept. 17, 2014






    7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063